Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Aliberti S, Ringshausen FC, Dhar R, Haworth CS, Loebinger MR, Dimakou K, Crichton ML, De Soyza A, Vendrell M, Burgel PR, McDonnell M, Skrgat S, Maiz Carro L, de Roux A, Sibila O, Bossios A, van der Eerden M, Kauppi P, Wilson R, Milenkovic B, Menendez R, Murris M, Borekci S, Munteanu O, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Van Braeckel E, Altenburg J, Shoemark A, Shteinberg M, Boersma W, Goeminne PC, Elborn JS, Hill AT, Welte T, Blasi F, Polverino E, Chalmers JD; EMBARC Registry Investigators.
Eur Respir J. 2024 Apr 18;63(4):2301554. doi: 10.1183/13993003.01554-2023. Print 2024 Apr.
Sputum handling for rheology.
Esteban Enjuto L, Robert de Saint Vincent M, Maurin M, Degano B, Bodiguel H.
Sci Rep. 2023 May 11;13(1):7695. doi: 10.1038/s41598-023-34043-9.
Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia.
Ito A, Ishida T, Tachibana H, Nakanishi Y, Kawataki M, Yamazaki A, Washio Y.
J Clin Microbiol. 2024 Apr 10;62(4):e0166523. doi: 10.1128/jcm.01665-23. Epub 2024 Mar 19.
Bronchiectasis.
ten Hacken N, Kerstjens H, Postma D.
BMJ Clin Evid. 2008 Jan 2;2008:1507.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.
Ann Intern Med. 1987 Feb;106(2):196-204. doi: 10.7326/0003-4819-106-2-196.
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T; EMBARC/BRR definitions working group.
Eur Respir J. 2017 Jun 8;49(6):1700051. doi: 10.1183/13993003.00051-2017. Print 2017 Jun.
Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.
Manjhi R, Nanda SK, Agrawal BK.
J Family Med Prim Care. 2022 Dec;11(12):7713-7719. doi: 10.4103/jfmpc.jfmpc_576_22. Epub 2023 Jan 17.
A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.
Chen K, Pleasants KA, Pleasants RA, Beiko T, Washburn RG, Yu Z, Zhai S, Drummond MB.
COPD. 2020 Jun;17(3):311-317. doi: 10.1080/15412555.2020.1766433. Epub 2020 May 27.
Enhancement of Pulmozyme activity in purulent sputum by combination with poly-aspartic acid or gelsolin.
Bucki R, Cruz K, Pogoda K, Eggert A, Chin L, Ferrin M, Imbesi G, Hadjiliadis D, Janmey PA.
J Cyst Fibros. 2015 Sep;14(5):587-93. doi: 10.1016/j.jcf.2015.02.001. Epub 2015 Feb 13.
Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
Spies R, Potter M, Hollamby R, van der Walt S, Hohlfeld A, Ochodo E, Van Zyl-Smit R.
Ann Am Thorac Soc. 2023 May;20(5):738-748. doi: 10.1513/AnnalsATS.202204-319OC.
